http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20071298-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-22
filingDate 2007-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c489664e849ce44a987997125e7482ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db08e93699f53b558c00a2fb406388d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4ff556fc538be8bdc1b6e10fe7fd0d
publicationDate 2007-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20071298-L
titleOfInvention Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
abstract The present invention relates to biocatalytic processes for the preparation of enantiomerically pure stereoisomers of 1- (2,6-dichloro-3-fluorophenyl) ethanol. Described are processes for the preparation of the S-enatiomer which are based on a combination of an asymmetric solution, chemical esterification and chemical hydrolysis with inversion of 1- (2,6-dichloro-3-fluorophenyl) ethyl esters or selective bioreduction and 1 - (2,6-dichloro-3-fluorophenyl) with a biocatalyst such as an enzyme or microorganism. The chiral enantiomer can be used in the synthesis of certain enantiomerically enriched ether-linked 2-amino-pyridine compounds that potently inhibit autophosphorylation of human heptocyte growth factor receptor.
priorityDate 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16770068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419730877

Total number of triples: 24.